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For anti HIV activity, Stavudine (or D4T or Zerit) is an important nucleoside reverse transcriptase inhibitor (NRTI). 
Molecular geometry of this compound has been optimized by DFT B3LYP/6–31G (d,p) method using Gaussian 03 software 
package. In order to examine global reactivity descriptors of the drug molecule, Frontier orbital analysis has been carried 
out. Using molecular docking inhibition activity of the drug against HIV-1 reverse transcriptase (6AN2) has been 
investigated. Attempts have been made to elucidate the chemical and biological properties of the drug.  
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Introduction 
The anti-HIV, 2´, 3´-didehydro-3´-deoxythymidine 
(stavudine or D4T or Zerit) belongs to the  
family of nucleoside reverse transcriptase inhibitors 
(NRTIs). Stavudine prevents HIV from altering the 
genetic material of healthy CD4 cells.1 It hinders 
living cells from producing new virus and decreases 
the amount of virus in the body. The present paper 
reports the structure, conformation, potential energy 
surface and simulation of this antiviral drug using 
quantum chemical methods. A plenty of literature 
dealing with the structural and/or conformational 
transitions in the drug molecule and its role in altering 
pharmacological effectiveness is presently available 
in literature.2,3 
 
Computational methods 
Molecular simulation and modelling are 
undergoing rapid development. They are increasingly 
important tools for fundamental and applied research 
in academia and industry in such diverse fields as 
drug-design and materials science.4–7 In the present 
investigation, the drug molecule and nucleic acid 
bases are optimized by B3LYP method8 with  
6–31G (d,p) basis set using Gaussian 03 program.9 
For molecular docking studies, SwissDock web server 
has been used.10  
 
Results and discussion 
 
Equilibrium geometry 
The molecular geometry of stavudine has been 
optimized by DFT (B3LYP) method with 6–31G (d,p) 
basis set using Gaussian 03 program. The optimized 
molecular geometry along with various atomic index 
numbers and bond lengths of drug molecule has been 
shown in Fig. 1. 
 
Frontier orbital analysis 
The HOMO and LUMO of stavudine are shown in 
Fig. 2. The electronic parameters of the drug are listed 
in Table 1. The calculated electronic parameters 
include ionization potential, electron affinity, absolute 
electronegativity and chemical hardness etc. These 
parameters are used to describe chemical reactivity of 
molecules.  
——————— 
*Author for Correspondence 
E-mail: nbsingh43@gmail.com  Fig. 1 — Equilibrium molecular geometry of stavudine drug 
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Table 1 — Electronic parameters of stavudine as calculated by 
B3LYP/6-31G(d,p) method 
Electronic Parameter 
HOMO energy -0.207 a.u. 
LUMO energy -0.044 a.u. 
Energy Gap (∆E) 0.163 a.u. 
Ionization Potential (I) 0.207 a.u. 
Electron Affinity (A) 0.044 a.u. 
Electronegativity (χ) 0.125 a.u. 
Electronic chemical potential (µ) -0.125 a.u. 
Global hardness (η) 0.081 a.u. 
Global softness (S) 12.34 a.u.-1 
Electrophilicity index (ω) 0.096 a.u. 
 
Molecular docking 
Molecular docking is a process that explores the 
binding of a drug molecule with a receptor and 
thereby estimates the effectiveness of drug. Thus 
docking has a great importance in the field of drug 
discovery.4, 5 In this process all possible conformers of 
the molecule (ligand) and their corresponding energy 
values are calculated and finally the best binding 
modes are ranked according to the full fitness (FF) 
score. In order to avoid sampling bias the whole 
docking process performed by SwissDock is blinded 
by covering the entire protein and not defining any 
specific region of the protein as bonding pocket. The 
resulting output clusters obtained after each run 
showed that cluster 0 is having the best full  
fitness (FF) score. The title compound shows anti 
HIV-1 activity, so we have performed the docking 
study of the drug with HIV-1 reverse transcriptase 
(PDB ID: 6AN2).11 The FF score and binding affinity 
obtained for protein targets clearly show that the drug 
molecule effectively bonded with 6AN2 target by 
forming two hydrogen bonds of 2.099Å and 2.432Å 
(FF score:-3512.208 kcal/mol, binding affinity ∆G = -
7.535 kcal/mol). The docking picture obtained from 
the UCSF chimera software is shown in Fig. 3. From 
this result, we can say that this compound effectively 
acts as an anti-HIV type-1 drug. 
 
Conclusion 
Chemical reactivity and charge transfer within the 
drug stavudine molecule has been elucidated by 
Frontier orbital surface analysis. Molecular docking 
suggested that drug elicits its potential antiviral 
activity against HIV by forming strong hydrogen 
bonding with 6AN2 receptor. 
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Fig. 2 — HOMO and LUMO of stavudine 
 
 
Fig. 3 — Molecular docking of stavudine with 6AN2 receptor 
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